Login / Signup

The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians.

Thu-Lan KellyMichael B WardNicole L PrattEmmae RamsayMarianne H GillamElizabeth Ellen Roughead
Published in: Respiratory research (2022)
Patients and doctors should be aware of the possible risk of COPD exacerbation with higher dose paracetamol 1 to 6 weeks after initiation or discontinuation, but no increased risk after 2 months.
Keyphrases
  • chronic obstructive pulmonary disease
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • lung function
  • patient reported outcomes
  • cystic fibrosis